LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 34

Search options

  1. Article ; Online: Inhibiting centrosome clustering reduces cystogenesis and improves kidney function in autosomal dominant polycystic kidney disease.

    Cheng, Tao / Mariappan, Aruljothi / Langner, Ewa / Shim, Kyuhwan / Gopalakrishnan, Jay / Mahjoub, Moe R

    JCI insight

    2024  Volume 9, Issue 4

    Abstract: Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder accounting for approximately 5% of patients with renal failure, yet therapeutics for the treatment of ADPKD remain limited. ADPKD tissues display abnormalities in the biogenesis ...

    Abstract Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder accounting for approximately 5% of patients with renal failure, yet therapeutics for the treatment of ADPKD remain limited. ADPKD tissues display abnormalities in the biogenesis of the centrosome, a defect that can cause genome instability, aberrant ciliary signaling, and secretion of pro-inflammatory factors. Cystic cells form excess centrosomes via a process termed centrosome amplification (CA), which causes abnormal multipolar spindle configurations, mitotic catastrophe, and reduced cell viability. However, cells with CA can suppress multipolarity via "centrosome clustering," a key mechanism by which cells circumvent apoptosis. Here, we demonstrate that inhibiting centrosome clustering can counteract the proliferation of renal cystic cells with high incidences of CA. Using ADPKD human cells and mouse models, we show that preventing centrosome clustering with 2 inhibitors, CCB02 and PJ34, blocks cyst initiation and growth in vitro and in vivo. Inhibiting centrosome clustering activates a p53-mediated surveillance mechanism leading to apoptosis, reduced cyst expansion, decreased interstitial fibrosis, and improved kidney function. Transcriptional analysis of kidneys from treated mice identified pro-inflammatory signaling pathways implicated in CA-mediated cystogenesis and fibrosis. Our results demonstrate that centrosome clustering is a cyst-selective target for the improvement of renal morphology and function in ADPKD.
    MeSH term(s) Humans ; Mice ; Animals ; Polycystic Kidney, Autosomal Dominant/pathology ; Cell Proliferation ; Kidney/pathology ; Centrosome/metabolism ; Fibrosis ; Cysts/metabolism ; Cysts/pathology
    Language English
    Publishing date 2024-02-22
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.172047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Aberrant centrosome biogenesis disrupts nephron progenitor cell renewal and fate resulting in fibrocystic kidney disease.

    Cheng, Tao / Agwu, Chidera / Shim, Kyuhwan / Wang, Baolin / Jain, Sanjay / Mahjoub, Moe R

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Mutations that disrupt centrosome structure or function cause congenital kidney developmental defects and fibrocystic pathologies. Yet, it remains unclear how mutations in proteins essential for centrosome biogenesis impact embryonic kidney development. ... ...

    Abstract Mutations that disrupt centrosome structure or function cause congenital kidney developmental defects and fibrocystic pathologies. Yet, it remains unclear how mutations in proteins essential for centrosome biogenesis impact embryonic kidney development. Here, we examined the consequences of conditional deletion of a ciliopathy gene,
    Highlights: Defective centrosome biogenesis in nephron progenitors causes:Reduced abundance of metanephric mesenchyme and premature differentiation into tubular structuresAbnormal branching morphogenesis leading to reduced nephron endowment and smaller kidneysChanges in cell-autonomous and paracrine signaling that drive cystogenesis and fibrosisUnique cellular and developmental defects when compared to Pkd1 knockout models.
    Language English
    Publishing date 2023-04-05
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.04.04.535568
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease.

    Cheng, Tao / Agwu, Chidera / Shim, Kyuhwan / Wang, Baolin / Jain, Sanjay / Mahjoub, Moe R

    Development (Cambridge, England)

    2023  Volume 150, Issue 24

    Abstract: Mutations that disrupt centrosome biogenesis or function cause congenital kidney developmental defects and fibrocystic pathologies. Yet how centrosome dysfunction results in the kidney disease phenotypes remains unknown. Here, we examined the ... ...

    Abstract Mutations that disrupt centrosome biogenesis or function cause congenital kidney developmental defects and fibrocystic pathologies. Yet how centrosome dysfunction results in the kidney disease phenotypes remains unknown. Here, we examined the consequences of conditional knockout of the ciliopathy gene Cep120, essential for centrosome duplication, in the nephron and collecting duct progenitor niches of the mouse embryonic kidney. Cep120 loss led to reduced abundance of both cap mesenchyme and ureteric bud populations, due to a combination of delayed mitosis, increased apoptosis and premature differentiation of progenitor cells. These defects resulted in dysplastic kidneys at birth, which rapidly formed cysts, displayed increased interstitial fibrosis and decline in kidney function. RNA sequencing of embryonic and postnatal kidneys from Cep120-null mice identified changes in the pathways essential for development, fibrosis and cystogenesis. Our study defines the cellular and developmental defects caused by centrosome dysfunction during kidney morphogenesis and identifies new therapeutic targets for patients with renal centrosomopathies.
    MeSH term(s) Animals ; Humans ; Mice ; Kidney/metabolism ; Nephrons/metabolism ; Centrosome/metabolism ; Polycystic Kidney Diseases/metabolism ; Mice, Knockout ; Fibrosis ; Cell Cycle Proteins/metabolism
    Chemical Substances Cep120 protein, mouse ; Cell Cycle Proteins
    Language English
    Publishing date 2023-12-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 90607-4
    ISSN 1477-9129 ; 0950-1991
    ISSN (online) 1477-9129
    ISSN 0950-1991
    DOI 10.1242/dev.201976
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Bioluminescent Tumor Signal Is Mouse Strain and Pelt Color Dependent: Experience in a Disseminated Lymphoma Model.

    Hoegger, Mark J / Longtine, Mark S / Shim, Kyuhwan / Wahl, Richard L

    Molecular imaging and biology

    2021  Volume 23, Issue 5, Page(s) 697–702

    Abstract: Background: Many preclinical cancer studies use mice with varied phenotypes to monitor tumor treatment. We compared survival and optical imaging characteristics of strains with varied coat colors harboring luciferase-expressing disseminated lymphoma.: ...

    Abstract Background: Many preclinical cancer studies use mice with varied phenotypes to monitor tumor treatment. We compared survival and optical imaging characteristics of strains with varied coat colors harboring luciferase-expressing disseminated lymphoma.
    Results: Luciferase-expressing lymphoma cells (Raji-luc) were injected via tail vein into severe combined immunodeficient (SCID) and Rag2-IL2rg (R2G2) mice, and survival was tracked. Tumor signals were obtained by imaging ventral and dorsal aspects of mice. Signal attenuation by isolated mouse pelts was measured in vitro. R2G2 mice had decreased survival compared to SCID mice (17 vs. 32 days, p<0.001) despite similar bioluminescence signal when mice were imaged dorsally (p=0.37). However, signal was 17.3-fold higher in R2G2 mice compared to SCID (p<0.001) when imaged ventrally. Isolated dark R2G2 dorsal pelts attenuated signal more than ventral pelts when placed over cells in vitro.
    Conclusions: Mouse pelt color and imaging aspect are critical considerations for quantifying bioluminescent tumor signal, and the R2G2 mouse strain may prove useful for preclinical targeted therapy studies.
    MeSH term(s) Animals ; Cell Line ; Disease Models, Animal ; Female ; Hair/physiology ; Luminescent Measurements/methods ; Lymphoma/classification ; Lymphoma/metabolism ; Lymphoma/pathology ; Lymphoma/therapy ; Mice ; Mice, SCID ; Mice, Transgenic ; Radiotherapy ; Skin Pigmentation/physiology
    Language English
    Publishing date 2021-04-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2079160-4
    ISSN 1860-2002 ; 1536-1632
    ISSN (online) 1860-2002
    ISSN 1536-1632
    DOI 10.1007/s11307-021-01594-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cure of Disseminated Human Lymphoma with [

    Longtine, Mark S / Shim, Kyuhwan / Hoegger, Mark J / Benabdallah, Nadia / Abou, Diane S / Thorek, Daniel L J / Wahl, Richard L

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2023  Volume 64, Issue 6, Page(s) 924–931

    Abstract: Immunotherapies that target the CD20 protein expressed on most non-Hodgkin lymphoma cells have improved clinical outcomes, but relapse is common. We ... ...

    Abstract Immunotherapies that target the CD20 protein expressed on most non-Hodgkin lymphoma cells have improved clinical outcomes, but relapse is common. We prepared
    MeSH term(s) Humans ; Mice ; Animals ; Tissue Distribution ; Mice, Inbred C57BL ; Neoplasm Recurrence, Local ; Lymphoma/pathology ; Lymphoma, Non-Hodgkin/drug therapy ; Immunoglobulin G ; Radioimmunotherapy ; Cell Line, Tumor
    Chemical Substances ofatumumab (M95KG522R0) ; Immunoglobulin G
    Language English
    Publishing date 2023-04-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.122.265167
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Cilioretinal Artery Occlusion after Endovascular Coil Embolization for Anterior Communicating Artery.

    Bae, Heewon / Kang, TaeGu / Jeong, Da-Eun / Shim, KyuHwan / Kang, MinJu

    Brain sciences

    2021  Volume 11, Issue 5

    Abstract: Unruptured intracranial aneurysms have a risk of rupture, so coil embolization is widely practiced as it preserves a patent artery. There are complications of coil procedures, such as patent artery occlusion and thromboembolism, which can result in ... ...

    Abstract Unruptured intracranial aneurysms have a risk of rupture, so coil embolization is widely practiced as it preserves a patent artery. There are complications of coil procedures, such as patent artery occlusion and thromboembolism, which can result in retinal artery occlusion. We report onretinal artery occlusion following coil embolization of anterior communicating artery aneurysm. This is a rare case of a combination of cilioretinal and branch retinal artery occlusion, and is unusual in showing a functional recovery.
    Language English
    Publishing date 2021-04-25
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci11050542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Possible Pathogenic PSEN2 Gly56Ser Mutation in a Korean Patient with Early-Onset Alzheimer's Disease.

    Shim, Kyu-Hwan / Kang, Min-Ju / Bae, Heewon / Kim, Danyeong / Park, Jiwon / An, Seong-Soo A / Jeong, Da-Eun

    International journal of molecular sciences

    2022  Volume 23, Issue 6

    Abstract: Early-onset Alzheimer’s disease (EOAD) is characterized by the presence of neurological symptoms in patients with Alzheimer’s disease (AD) before 65 years of age. Mutations in pathological genes, including amyloid protein precursor (APP), presenilin-1 ( ... ...

    Abstract Early-onset Alzheimer’s disease (EOAD) is characterized by the presence of neurological symptoms in patients with Alzheimer’s disease (AD) before 65 years of age. Mutations in pathological genes, including amyloid protein precursor (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2), were associated with EOAD. Seventy-six mutations in PSEN2 have been found around the world, which could affect the activity of γ-secretase in amyloid beta processing. Here, a heterozygous PSEN2 point mutation from G to A nucleotide change at position 166 (codon 56; c.166G>A, Gly56Ser) was identified in a 64-year-old Korean female with AD with progressive cognitive memory impairment for the 4 years prior to the hospital visit. Hippocampal atrophy was observed from magnetic resonance imaging-based neuroimaging analyses. Temporal and parietal cortex hypometabolisms were identified using fluorodeoxyglucose positron emission tomography. This mutation was at the N-terminal portion of the presenilin 2 protein on the cytosolic side. Therefore, the serine substitution may have promoted AD pathogenesis by perturbing to the mutation region through altered phosphorylation of presenilin. In silico analysis revealed that the mutation altered protein bulkiness with increased hydrophilicity and reduced flexibility of the mutated region of the protein. Structural changes were likely caused by intramolecular interactions between serine and other residues, which may have affected APP processing. The functional study will clarify the pathogenicity of the mutation in the future.
    MeSH term(s) Alzheimer Disease/diagnosis ; Alzheimer Disease/genetics ; Amyloid beta-Peptides/genetics ; Amyloid beta-Protein Precursor/genetics ; Female ; Humans ; Middle Aged ; Mutation ; Presenilin-1/genetics ; Presenilin-2/genetics ; Republic of Korea ; Serine/genetics
    Chemical Substances Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; PSEN2 protein, human ; Presenilin-1 ; Presenilin-2 ; Serine (452VLY9402)
    Language English
    Publishing date 2022-03-09
    Publishing country Switzerland
    Document type Case Reports ; Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23062967
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cure of Disseminated Human Lymphoma with [

    Shim, Kyuhwan / Longtine, Mark S / Abou, Diane S / Hoegger, Mark J / Laforest, Richard S / Thorek, Daniel L J / Wahl, Richard L

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2022  Volume 64, Issue 4, Page(s) 542–548

    Abstract: Although immunotherapies that target CD20 on most non-Hodgkin lymphoma (NHL) cells have improved patient outcomes, current therapies are inadequate because many cases are, or become, refractory or undergo relapse. Here, we labelled the third-generation ... ...

    Abstract Although immunotherapies that target CD20 on most non-Hodgkin lymphoma (NHL) cells have improved patient outcomes, current therapies are inadequate because many cases are, or become, refractory or undergo relapse. Here, we labelled the third-generation human anti-CD20 antibody ofatumumab with
    MeSH term(s) Humans ; Mice ; Animals ; Tissue Distribution ; Radioimmunotherapy ; Mice, Inbred C57BL ; Neoplasm Recurrence, Local ; Lymphoma ; Radiopharmaceuticals/therapeutic use ; Immunoglobulin G ; Lutetium/therapeutic use ; Cell Line, Tumor
    Chemical Substances ofatumumab (M95KG522R0) ; Radiopharmaceuticals ; Immunoglobulin G ; Lutetium (5H0DOZ21UJ)
    Language English
    Publishing date 2022-11-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.122.264816
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.

    Tran, Vy Anh / Vo, Van Giau / Shim, Kyuhwan / Lee, Sang-Wha / An, Seong Soo A

    International journal of nanomedicine

    2020  Volume 15, Page(s) 7667–7685

    Abstract: Background: Core-shell types of mesoporous silica nanoparticles (MSNs) with multimodal functionalities were developed for bio-imaging, controlled drug release associated with external pH, and near-infrared radiation (NIR) stimuli, and targeted and ... ...

    Abstract Background: Core-shell types of mesoporous silica nanoparticles (MSNs) with multimodal functionalities were developed for bio-imaging, controlled drug release associated with external pH, and near-infrared radiation (NIR) stimuli, and targeted and effective chemo-photothermal therapeutics.
    Materials and methods: We synthesized and developed a core-shell type of mesoporous silica nanocarriers for fluorescent imaging, stimuli-responsive drug release, magnetic separation, antibody targeting, and chemo-photothermal therapeutics. Also, the biocompatibility, cellular uptake, cytotoxicity, and photothermal therapy on these FS3-based nanocarriers were systematically investigated.
    Results: Magnetic mesoporous silica nanoparticles was prepared by coating a Fe
    Conclusion: Along with the facile synthesis of FS3-based nanocarriers, the integration of all these strategies into one single unit will be a prospective candidate for biomedical applications, especially in chemo-photothermal therapeutics, targeted delivery, and stimuli-responsive controlled drug release against multiple cancer cell types.
    MeSH term(s) Cisplatin ; Doxorubicin/pharmacology ; Drug Carriers/chemistry ; Drug Liberation ; Ferric Compounds/chemistry ; Graphite/chemistry ; HEK293 Cells ; HeLa Cells ; Humans ; Hyperthermia, Induced ; Indoles/chemistry ; Nanoparticles/chemistry ; Neoplasms/pathology ; Neoplasms/therapy ; Phototherapy ; Polymers/chemistry ; Porosity ; Silicon Dioxide/chemistry
    Chemical Substances Drug Carriers ; Ferric Compounds ; Indoles ; Polymers ; graphene oxide ; polydopamine ; ferric oxide (1K09F3G675) ; Silicon Dioxide (7631-86-9) ; Graphite (7782-42-5) ; Doxorubicin (80168379AG) ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2020-10-08
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2364941-0
    ISSN 1178-2013 ; 1176-9114
    ISSN (online) 1178-2013
    ISSN 1176-9114
    DOI 10.2147/IJN.S254344
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2).

    Vo, Van Giau / Bagyinszky, Eva / Shim, Kyuhwan / Park, Yoon Soo / An, Seong Soo A

    Molecular & cellular toxicology

    2020  Volume 16, Issue 4, Page(s) 355–357

    Abstract: Purpose of review: Within the last two decades several members of the Coronaviridae family namely Severe Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) have demonstrated epidemic potential. In late, 2019 an unnamed ... ...

    Abstract Purpose of review: Within the last two decades several members of the Coronaviridae family namely Severe Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) have demonstrated epidemic potential. In late, 2019 an unnamed genetic relative, later named SARS-CoV-2 realized its potential in the highly populous neighborhoods of Wuhan, China. Unchecked, the virus rapidly spread among interconnected communities and related households before containment measures could be in acted. "Appropriate" diagnostic testing in response to the SARS-CoV-2 outbreak should be urgently considered. This perspective review gives particular attention to the potential diagnostic testing of the virus in semen and seminal fluids due to its high levels of angiotensin converting enzyme 2 (ACE2) precursor.
    Recent findings: As many infectious viruses are stable in semen and have transmitted the respective diseases, the presence of SARS-CoV-2 should be tested in semen to assess their stabilities and half-life. As in case of Ebola virus, it was present in semen for longer period in a carrier man without any symptom. Additional hypothesis is that since ACE2 could serve as a mediator for the endocytosis of the previously SARS coronavirus, SARS-CoV-2 may enter the cells through similar mechanism. From the protein expression atlas, high levels of ACE2 precursor were found in intestines and testis. Hence, the testis and seminal fluids could be the host cell and/or reservoir. The results could be used as a suggestive guideline for the sexual activities after the discharge or declaration of disease free.
    Keywords covid19
    Language English
    Publishing date 2020-07-07
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2498324-X
    ISSN 2092-8467 ; 1738-642X
    ISSN (online) 2092-8467
    ISSN 1738-642X
    DOI 10.1007/s13273-020-00096-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top